Abstract

Quality cancer care requires accurate and precise risk stratification, especially for early stage cancers. A large proportion of incident bladder cancer cases are diagnosed at early stage (

Public Health Relevance

Bladder cancer affects over 70,000 people every year and can require expensive and invasive treatment. This project will improve our knowledge about which tumors are likely to progress to lethal disease. A system that could tell doctors how frequently a patient should be tested for recurrence and progression could greatly improve both care and costs. We will develop such a system for use in different healthcare settings.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21CA191610-02
Application #
8989082
Study Section
Special Emphasis Panel (ZCA1-SRB-2 (O1))
Program Officer
Doriarose, Vincent P
Project Start
2015-01-01
Project End
2016-12-31
Budget Start
2016-01-01
Budget End
2016-12-31
Support Year
2
Fiscal Year
2016
Total Cost
$170,396
Indirect Cost
$49,955

  Institution

Name
Kaiser Foundation Research Institute
Department
Type
DUNS #
150829349
City
Oakland
State
CA
Country
United States
Zip Code
94612

  Publications

Garg, Tullika; Young, Amanda J; O'Keeffe-Rosetti, Maureen et al. (2018) Association between treatment of superficial bladder cancer and 10-year mortality in older adults with multiple chronic conditions. Cancer 124:4477-4485